Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients

Phase 3

Completed

• Conditions: Venous Thromboembolism

• Registration Number: NCT00333021
• Lead Sponsor: GlaxoSmithKline

Brief Summary

This study is phase 3 study for prevention of VTE in patients with abdominal surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-05
• Study First Submitted: 2006-06-01
• Study First Submitted QC: 2006-06-01
• Study First Posted: 2006-06-02
• Study Completion: 2007-02
• Status Verified: 2009-07
• Last Update Submitted: 2009-07-09
• Last Update Posted: 2009-07-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 127

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Incidence of Venous thromboembolism and Major bleeding	Throughout entire study

Secondary Outcome Measures

Name	Time	Method
Incidence of Pulmonary embolism Incidence of Deep vein thrombosis Incidence of symptomatic Venous thromboembolism	Throughout entire study

Trial Locations

Locations (1)

GSK Investigational Site; 🇯🇵 Tokyo, Japan